# FDA Inspection 1126904 - Dipharma Francis Srl - April 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/dipharma-francis-srl/419b092b-abf5-474a-b479-5ef3d33e06be
Source feed: FDA_Inspections

> FDA Inspection 1126904 for Dipharma Francis Srl on April 20, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1126904
- Company Name: Dipharma Francis Srl
- Inspection Date: 2018-04-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1202251 - 2022-02-25](https://www.keypedia.com/records/fda_inspections/dipharma-francis-srl/45629f95-9063-404e-bf3e-5fff56bcb914)
- [FDA Inspection 1019767 - 2017-04-28](https://www.keypedia.com/records/fda_inspections/dipharma-francis-srl/6ac18949-807b-4548-8f8c-f0fd29b2e8bc)
- [FDA Inspection 871282 - 2014-03-07](https://www.keypedia.com/records/fda_inspections/dipharma-francis-srl/e9d97dc1-54eb-4d6e-9497-0f7b241d3891)
- [FDA Inspection 705342 - 2010-12-20](https://www.keypedia.com/records/fda_inspections/dipharma-francis-srl/44f282be-6232-4977-bc88-6552e881e2ae)

Company: https://www.keypedia.com/companies/dipharma-francis-srl/a190fccc-b852-4a67-abe1-5b30adaaeadd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c